Delivery Order SPE2DB22D2007-SPE2DB25FH9NF

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,460.22, is for the delivery of 4,567,012,938 units of 5 mg Oxycodone HCL immediate-release tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $1,347.18. The award was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,564,167,843 units of Oxycodone HCl (IR) 5 mg tablets. The contract has an ultimate completion date of March 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,166.60 firm fixed-price delivery order is for the supply of 4,566,556,083 units of Oxycodone HCl (IR) 5 mg tablets in 100-count bottles, with a completion date of November 27, 2024. AmerisourceBergen is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,108,069 units of oxycodone hydrochloride 5 mg tablets in 100-count bottles. The contract has a firm fixed price of $1,573.14 and a completion date of May 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,018.34 firm fixed-price delivery order contract is for the supply of 4,558,083,526 tablets of 10 mg Oxycodone HCL ER, a pain management medication. The contract has an ultimate completion date of August 15, 2022 and does not appear to have any set-aside requirements. AmerisourceBergen holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,814,520 units of Oxycodone HCL (IR) 5 mg tablets in 100-count bottles, with a total ceiling value of $1,532.87. The contract is a firm-fixed-price delivery order, with an ultimate completion date of June 6, 2024. This contract is not designated as a set-aside....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides 4,555,372,493 units of Oxycodone HCL 5 mg tablets to the Defense Logistics Agency (DLA). The $2,257.83 firm fixed-price delivery order has a completion date of November 10, 2021. The contract is not designated as a set-aside. Amerisourcebergen, a subsidiary of Cencora, Inc., holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,128.62, is a delivery order for the supply of 4,568,062,087 tablets of OxyContin ER 20 mg. The contract has an ultimate completion date of April 29, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DX15D1022|SPE2DX25FVETA, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,541.76 firm fixed-price delivery order is for the supply of 4,568,088,905 units of the prescription medication oxycodone hydrochloride immediate-release 5 mg tablets. The contract has an ultimate completion date of May 1, 2025 and was awarded on April 30, 2025. This award...
This federal contract award, valued at $1,884.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,250,443 units of Oxycodone Hydrochloride 5 mg/5 ml oral solution, a pharmaceutical product used for pain management. This is a firm-fixed price delivery order contract that runs through February 13, 2025. No set-aside designation was used for this award....
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH9NF
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,471.18 firm-fixed-price delivery order is for the supply of 4,567,460,541 units of 5 mg oxycodone HCL immediate-release tablets. The contract has an ultimate completion date of March 5, 2025 and was awarded on March 4, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 7/1/25, 6:24 AM